Introduction
Oral pre‐exposure prophylaxis (Pr
EP
) for
HIV
prevention has been proven to significantly reduce new
HIV
infections yet scale‐up has been slow. As contexts continue to adjust to make space for Pr
EP
, it is crucial to understand the perspectives and experiences of potential end‐users. In order to inform Pr
EP
and demand creation interventions, this paper examines personal perspectives on adopting and using Pr
EP
among
HIV
at‐risk populations in sub‐Saharan Africa.
Methods
Using the principles of a scoping review in July 2018, we explored the extent, range, and nature of published literature regarding Pr
EP
uptake and use among; men who have sex with men,
HIV
serodiscordant couples, adolescent girls and young women, pregnant and breastfeeding women, women partners of migrant workers; and people who use drugs. Steps included: identification of the research question; identification of relevant studies; study selection; charting the data; and collation – summarizing and reporting results. PubMed and PsycInfo were searched for papers relating to Pr
EP
uptake and use in sub‐Saharan Africa. Resulting papers were reviewed with data extracted and compiled in Excel for analysis. A broad content analysis was conducted and organized into high‐level themes.
Results and discussion
Thirty‐five papers were included in this review. There was little opposition in general to oral Pr
EP
; however, there were significant nuances in its broader acceptability, applicability, and usability. We identified five themes within which these are discussed. These relate to balancing complexities of personal empowerment and stigma; navigating complex risk environments; influences of relationships and partners; efficacy and side effects; and practicalities of use. This body of research suggests that while product attributes and the logistics of Pr
EP
delivery and use are important topics, it is vital to consider stigma, the interactions of Pr
EP
use with relationships, and the need for broader understanding of
ARV
s for prevention versus treatment.
Conclusions
Planning for, programming and promoting the adoption of oral Pr
EP
necessitates a deeper understanding of end‐user priorities in order to ensure successful interventions. This review illustrates the nuances facilitating or deterring Pr
EP
use that may affect the larger effort of Pr
EP
scale‐up.